
                     
                     
                     Drug Interactions
                     
                        Caution should be exercised when Propranolol Hydrochloride Extended-Release Capsules, USP, are administered with drugs that have an affect on CYP2D6, 1A2, or 2C19 metabolic pathways. Co-administration of such drugs with propranolol may lead to clinically relevant drug interactions and changes on its efficacy and/or toxicity (see 
                              Drug Interactions
                            in 
                              PHARMACOKINETICS AND DRUG METABOLISM
                           ).
                        
                           Alcohol when used concomitantly with propranolol, may increase plasma levels of propranolol.
                     
                     
                  
               